Home
>
National Drug Code (NDC)
>
OZURDEX
OZURDEX - 0023-3348-08 - (dexamethasone)
Drug Information of OZURDEX
| Product NDC: | 0023-3348 |
| Proprietary Name: | OZURDEX |
| Non Proprietary Name: | dexamethasone |
| Active Ingredient(s): | .7 mg/1 & nbsp; dexamethasone |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | IMPLANT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of OZURDEX
| Product NDC: | 0023-3348 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022315 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090901 |
Package Information of OZURDEX
| Package NDC: | 0023-3348-08 |
| Package Description: | 1 POUCH in 1 CARTON (0023-3348-08) > 1 IMPLANT in 1 POUCH |
NDC Information of OZURDEX
| NDC Code | 0023-3348-08 |
| Proprietary Name | OZURDEX |
| Package Description | 1 POUCH in 1 CARTON (0023-3348-08) > 1 IMPLANT in 1 POUCH |
| Product NDC | 0023-3348 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dexamethasone |
| Dosage Form Name | IMPLANT |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 20090901 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | DEXAMETHASONE |
| Strength Number | .7 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
